Biotech

Jennerex's Drug Candidate, JX-929, Named as One of the Top 10 Oncology Projects to Watch

SAN FRANCISCO, CA: Company to Present at Windhover's Therapeutic Area Partnerships Conference November 29 ...

Prana Completes Recruitment in Alzheimer's Trial

MELBOURNE, AUSTRALIA: 12 Month Phase II Study With PBT2 in Early Alzheimer's Patients ...

Triplefin Acquires Interest in Specialty Pharmacy Nursing Network (SPNN)

CINCINNATI, OH: ...

HTG Molecular Diagnostics and PROOF Centre Partner to Commercialize COPD Prognostic Test

TUCSON, AZ: ...

Immunovative, Inc. Further Enhances Its Intellectual Property Portfolio Through Grant of Another Key U.S. Patent, Entitled: METHOD FOR STIMULATING A THERAPEUTIC IMMUNE EFFECT IN A PATIENT (U.S. Patent No. 8,298,587)

NEW YORK, NY: ...

ProTrials Adds Diane Wong as Director of Quality Assurance

SUNNYVALE, CA: ProTrials Continues Growth Expansion, Adds Experienced Quality Assurance and GCP Compliance Auditor to Its Team ...

Media Advisory: Genome Canada

OTTAWA, ONTARIO: ...

MethylGene to Present at the Piper Jaffray 24th Annual Healthcare Conference

MONTREAL, QUEBEC: ...

Paladin Labs Announces the Canadian Launch of Oralair(TM)

MONTREAL, CANADA: - Oralair is the first allergen immunotherapy tablet to be launched in Canada for treating the symptoms of moderate to severe grass pollen allergies - Oralair tablets provide patients with a safe, eff ...

Prana to Present at New York Academy of Science Symposium on November 29th

MELBOURNE, AUSTRALIA: "Targeting Metals in Alzheimer's and Other Neurodegenerative Diseases" ...